Diabetes and Cardiovascular Disease - Protocols for Safe Use of SGLT2i and GLP1RA in Hospital Settings

Learn about the critical intersection of diabetes and cardiovascular disease through a comprehensive cardiology rounds presentation delivered by Dr. Kim Connelly, Staff Cardiologist at St. Michael's Hospital. Explore detailed protocols and safety guidelines for implementing SGLT2 inhibitors and GLP-1 receptor agonists (GLP1RA) in hospital settings. Gain valuable insights into managing diabetic patients with cardiovascular complications and understand the latest evidence-based approaches for using these therapeutic agents effectively and safely in clinical practice. Master the nuances of inpatient diabetes management while considering cardiovascular risk factors and treatment strategies that optimize patient outcomes.